Don’t Add Anakinra to Your COVID-19 Treatment Protocol

January 2023

You’ll hear about anakinra (Kineret) to treat patients admitted with COVID-19...due to a new emergency use authorization.

This IL-1 inhibitor is now authorized for certain adults with SARS-CoV-2 at risk of progressing to severe respiratory failure.

These are patients on low- or high-flow supplemental oxygen...but NOT noninvasive or mechanical ventilation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote